Strategic Development

Strategic Positioning

Global Integrated Platform for Original Innovation in Biopharmaceuticals

Core Strategies

Dual-Track Development

Committed to first-in-class mechanisms and differentiated target positioning, continuously advancing our two core technology platforms: small molecules and macromolecular therapeutics.

Global Licensing

Leveraging our strong research capabilities, actively advancing dual filings in China and the US for pipeline assets, achieving rapid global expansion through License-Out strategies.

Global Operations

Building on premier research capabilities, global industry networks, and capital resources, rapidly establishing a worldwide operational matrix through organic growth and M&A.